Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.

Stenger EO, Chinnadurai R, Yuan S, Garcia M, Arafat D, Gibson G, Krishnamurti L, Galipeau J.

Biol Blood Marrow Transplant. 2017 May;23(5):736-745. doi: 10.1016/j.bbmt.2017.01.081. Epub 2017 Jan 26.

PMID:
28132869
2.

Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation.

Stenger EO, Krishnamurti L, Galipeau J.

BMC Immunol. 2015 Dec 16;16:74. doi: 10.1186/s12865-015-0135-7. Review.

3.
4.

Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.

Stenger EO, Chiang KY, Haight A, Qayed M, Kean L, Horan J.

Biol Blood Marrow Transplant. 2015 Oct;21(10):1845-52. doi: 10.1016/j.bbmt.2015.06.005. Epub 2015 Jun 19.

5.

IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.

Stenger EO, Rosborough BR, Mathews LR, Ma H, Mapara MY, Thomson AW, Turnquist HR.

Biol Blood Marrow Transplant. 2014 Feb;20(2):192-201. doi: 10.1016/j.bbmt.2013.11.007. Epub 2013 Nov 12.

6.

Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Stenger EO, Turnquist HR, Mapara MY, Thomson AW.

Blood. 2012 May 31;119(22):5088-103. doi: 10.1182/blood-2011-11-364091. Epub 2012 Mar 7. Review.

Supplemental Content

Loading ...
Support Center